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66a Sunday, February 26, 2012cancer. In vitro treatment of tumor cells with Irvalec induces necrotic
cell death, a process associated with rapid loss of membrane integrity and
subsequent cell permeabilization. These results suggested an effect of the
drug, either on an ion channel or in the plasma membrane. In order to explore
this hypothesis patch-clamp experiments were performed in different
tumor cell lines (HeLa, A549 and HCT116). Treated cells underwent rapid
and dramatic morphological changes, including cell blebbing, severe swell-
ing, plasma membrane permeabilization and cell lysis. Apart from the numer-
ous small blebs, membranes from damaged cells also re-organized to
form enormous bubbles surrounded by cell membrane. Using electrophysio-
logical techniques, it was shown that Irvalec induced an important increase
in membrane conductance. The compound permeabilized the plasma
membrane to ions, even when the cells were not pulsed, causing important
changes in the holding current. It has been described that zinc attenuates
the drastic effects of some membrane disrupting agents. Hence, to test if
zinc exerted some protective effect against Irvalec effects, cells were
treated with this drug in the presence or absence of zinc salts and its
membrane permeability was analyzed by using electrophysiology techniques,
measuring the variations in the ion currents induced by the drug. Interestingly,
in cells treated with zinc (10 mM), a decrease in the membrane permeability
induced by Irvalec was observed. Altogether, these results suggest that
Irvalec induces a rapid membrane permeabilization that lead to a necrotic
cell death.
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Bone morphogenetic proteins (BMP2) are key regulators during mesenchymal
stem (MSC) cell differentiation; however how these growth factors achieve lin-
eage specification is not well understood. BMP-2, a frequently studied BMP, is
known to induce adipogenesis, chondrogenesis and osteogenesis in MSCs,
however the exact dynamics leading to the determination of the fate of the
stem cell is not well understood. We hypothesize those regions on the plasma
membrane, where BMP-2 binds direct signaling pathway and therefore regulate
stem cell fate.
In order to determine the dynamics of BMP2 and binding sites on the plasma
membrane we covalently link Quantum Dots (QDs) to BMP-2. Creating stable
fluorescent BMP2 allowed for the first time measurements of BMP2 dynamics
on the cell surface in real time. QD’s, semi-conducting nanocrystals, superior to
conventional organic dyes, are highly efficient due to high extinction coeffi-
cient and stability (minimizing photo bleaching), which are 20 times brighter
and 100 times more stable than traditional fluorescent reporters. Additionally
results were verified using combined AFM and Confocal imaging. Using
mutated RFP tagged BMP type - I receptors, or gfp tagged caveolin-1 or AP-2
constructs we were able to identify different regions important for osteogenesis,
chondrogenesis and adipogenesis. Further using these data combinedwith a sys-
tems biology approach created a signaling model for BMP2 during stem cell
differentiation.
Our data indicate BMP2 interacts with receptors localized in caveolae and
clathrin coated pits and these domains are key regions for signaling. Depen-
dent on BMP receptor localization MSCs are directed toward specific stem
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As reported by Mach and co-workers CD40 ligand is involved in the vascular
infiltration of immune cells and development of atherosclerotic lesions. Ac-
cordingly, it was found that the pathogenesis of atherosclerosis was attenuated
in CD40L-/- mice compared to the wild-type mice based on a reduction of mac-
rophage and CD4þ T cells migration into the atherosclerotic plaque. Further-
more, T cell mediated CD40L release, in turn, led to thrombocyte and
macrophage activation in thrombosis. Here, we show that CD40L plays an im-
portant role in the intravascular Angiotensin-II-induced inflammatory process
and analyzed the function of CD40 ligand during Angiotensin-II-induced oxi-
dative stress and vascular dysfunction in arterial hypertension.
In an established murine model we used osmotic minipumps containing angio-
tensin II (1mg/kg/d). Vascular function was recorded by isometric tension stud-
ies, reactive oxygen species (ROS) were monitored in blood and heart of
CD40L-/- mice by using enhanced chemiluminescence. ELISA of CD4þ T
cell supernatants as well as Western blot analysis and realtime RT-PCR have
been used to analyze the expression of pro-inflammatory cytokines, NAPDH
oxidase subunits and T cell transcription factors.
CD40L-/- mice showed an ameliorated endothelial function and decreased ox-
idative stress in the heart and blood after angiotensin II treatment compared to
their wild-type littermates. Moreover, CD40L-/- mice displayed significantly
decreased levels of Th1 cytokines released by splenic CD4þ T cells. This ob-
servation was accompanied by lower expression levels of NOX-2 in aorta and
splenic T-bet as well as P-Selectin ligand from CD40L-/- mice. In summary,
our results demonstrate that CD40L-/- deficiency improves angiotensin II in-
duced vascular dysfunction and oxidative stress further supporting our previous
observations [Wenzel et al. Circulation 2011] that immune cells and inflamma-
tory pathways significantly contribute to angiotensin II induced arterial
hypertension.
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Riboflavin ligands present an alternative pathway for targeted drug delivery as
riboflavin receptors are over-expressed in breast and prostate cancer cells. We
have examined dendrimers conjugated with riboflavin for targeting riboflavin
binding protein, which acts as a model protein for the riboflavin receptor.
Isothermal titration calorimetry (ITC) was used for determining the
thermodynamic parameters for this binding interaction while varying location
and average number of riboflavin attached to the dendrimer. Differential scan-
ning calorimetry (DSC) was additionally used to confirm the trends observed
by ITC. By characterizing the binding interactions between riboflavin dendrimer
conjugates and the riboflavin binding protein, the efficacy of this platform for
a targeted approach of drug delivery can be predictedmore accurately. The ribo-
flavin dendrimer conjugates will be used in future studies to target riboflavin re-
ceptors for cellular uptake as a potential route for the selective delivery of drug
molecules to cancer cells that over-express riboflavin receptors.
